189 related articles for article (PubMed ID: 11371930)
1. Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer.
Hautmann SH; Lokeshwar VB; Schroeder GL; Civantos F; Duncan RC; Gnann R; Friedrich MG; Soloway MS
J Urol; 2001 Jun; 165(6 Pt 1):2068-74. PubMed ID: 11371930
[TBL] [Abstract][Full Text] [Related]
2. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer.
Lokeshwar VB; Rubinowicz D; Schroeder GL; Forgacs E; Minna JD; Block NL; Nadji M; Lokeshwar BL
J Biol Chem; 2001 Apr; 276(15):11922-32. PubMed ID: 11278412
[TBL] [Abstract][Full Text] [Related]
3. Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade.
Lokeshwar VB; Obek C; Pham HT; Wei D; Young MJ; Duncan RC; Soloway MS; Block NL
J Urol; 2000 Jan; 163(1):348-56. PubMed ID: 10604388
[TBL] [Abstract][Full Text] [Related]
4. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.
Franzmann EJ; Schroeder GL; Goodwin WJ; Weed DT; Fisher P; Lokeshwar VB
Int J Cancer; 2003 Sep; 106(3):438-45. PubMed ID: 12845686
[TBL] [Abstract][Full Text] [Related]
5. [Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers].
Hautmann SH; Schroeder GL; Civantos F; Duncan RC; Gnann R; Friedrich MG; Hellstern A; Huland H; Soloway MS; Lokeshwar VB
Urologe A; 2001 Mar; 40(2):121-6. PubMed ID: 11315586
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer.
Posey JT; Soloway MS; Ekici S; Sofer M; Civantos F; Duncan RC; Lokeshwar VB
Cancer Res; 2003 May; 63(10):2638-44. PubMed ID: 12750291
[TBL] [Abstract][Full Text] [Related]
7. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.
Hautmann S; Toma M; Lorenzo Gomez MF; Friedrich MG; Jaekel T; Michl U; Schroeder GL; Huland H; Juenemann KP; Lokeshwar VB
Eur Urol; 2004 Oct; 46(4):466-71. PubMed ID: 15363562
[TBL] [Abstract][Full Text] [Related]
8. Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests.
Lokeshwar VB; Schroeder GL; Selzer MG; Hautmann SH; Posey JT; Duncan RC; Watson R; Rose L; Markowitz S; Soloway MS
Cancer; 2002 Jul; 95(1):61-72. PubMed ID: 12115318
[TBL] [Abstract][Full Text] [Related]
9. HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade.
Lokeshwar VB; Block NL
Urol Clin North Am; 2000 Feb; 27(1):53-61. PubMed ID: 10696245
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid/ Hyaluronidase as biomarkers for bladder cancer: a diagnostic meta-analysis.
Liang Z; Zhang Q; Wang C; Shi F; Cao H; Yu Y; Zhang M; Liu X
Neoplasma; 2017; 64(6):901-908. PubMed ID: 28895415
[TBL] [Abstract][Full Text] [Related]
11. HYAL1 overexpression is correlated with the malignant behavior of human breast cancer.
Tan JX; Wang XY; Li HY; Su XL; Wang L; Ran L; Zheng K; Ren GS
Int J Cancer; 2011 Mar; 128(6):1303-15. PubMed ID: 20473947
[TBL] [Abstract][Full Text] [Related]
12. Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1.
Lokeshwar VB; Young MJ; Goudarzi G; Iida N; Yudin AI; Cherr GN; Selzer MG
Cancer Res; 1999 Sep; 59(17):4464-70. PubMed ID: 10485499
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity and specificity of urinary hyaluronic acid and hyaluronidase in detection of bladder transitional cell carcinoma.
Jamshidian H; Hashemi M; Nowroozi MR; Ayati M; Bonyadi M; Najjaran Tousi V
Urol J; 2014 Mar; 11(1):1232-7. PubMed ID: 24595930
[TBL] [Abstract][Full Text] [Related]
14. One-step facile synthesis of hyaluronic acid functionalized fluorescent gold nanoprobes sensitive to hyaluronidase in urine specimen from bladder cancer patients.
Cheng D; Han W; Yang K; Song Y; Jiang M; Song E
Talanta; 2014 Dec; 130():408-14. PubMed ID: 25159428
[TBL] [Abstract][Full Text] [Related]
15. A side by side comparison of cytology and biomarkers for bladder cancer detection.
Schroeder GL; Lorenzo-Gomez MF; Hautmann SH; Friedrich MG; Ekici S; Huland H; Lokeshwar V
J Urol; 2004 Sep; 172(3):1123-6. PubMed ID: 15311054
[TBL] [Abstract][Full Text] [Related]
16. Secretion of bladder tumor-derived hyaluronidase activity by invasive bladder tumor cells.
Lokeshwar VB; Soloway MS; Block NL
Cancer Lett; 1998 Sep; 131(1):21-7. PubMed ID: 9839616
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid and hyaluronidase as possible novel urine biomarkers for the diagnosis of prostate cancer.
Skarmoutsos I; Skarmoutsos A; Katafigiotis I; Tataki E; Giagini A; Adamakis I; Alamanis C; Duvdevani M; Sitaras N; Constantinides C
Med Oncol; 2018 May; 35(7):97. PubMed ID: 29802604
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer.
Ekici S; Cerwinka WH; Duncan R; Gomez P; Civantos F; Soloway MS; Lokeshwar VB
Int J Cancer; 2004 Oct; 112(1):121-9. PubMed ID: 15305383
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of HYAL1 expression in breast cancer promoted tumor cell proliferation, migration, invasion and angiogenesis.
Tan JX; Wang XY; Su XL; Li HY; Shi Y; Wang L; Ren GS
PLoS One; 2011; 6(7):e22836. PubMed ID: 21829529
[TBL] [Abstract][Full Text] [Related]
20. Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer.
Eissa S; Swellam M; Shehata H; El-Khouly IM; El-Zayat T; El-Ahmady O
J Urol; 2010 Feb; 183(2):493-8. PubMed ID: 20006858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
